CHO Pharma, Inc. (TPEX:6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
28.15
-0.30 (-1.05%)
Jan 22, 2026, 11:40 AM CST
-45.23%
Market Cap6.09B
Revenue (ttm)3.21M
Net Income (ttm)-230.38M
Shares Out214.01M
EPS (ttm)-1.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume70,305
Average Volume453,412
Open28.45
Previous Close28.45
Day's Range27.90 - 28.50
52-Week Range25.80 - 68.80
Beta-0.54
RSI46.28
Earnings DateMar 23, 2026

About CHO Pharma

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengineered biobetter or ADC. In addition, the company develops CHO-H01, which... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements